Generation of an epigenetic signature by chronic hypoxia in prostate cells

Human Molecular Genetics

Volumn 18, Issue 19, 2009, Pages 3594-3604

  Watson, Jenny A ^a   Watson, Chris J ^a   McCrohan, Ann Maria ^a   Woodfine, Kathryn ^b   Tosetto, Miriam ^c   McDaid, Jennifer ^d   Gallagher, Emma ^a   Betts, David ^d   Baugh, John ^a   O'Sullivan, Jacintha ^c   Murrell, Adele ^b   Watson, R William G ^a   McCann, Amanda ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^d OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA METHYLTRANSFERASE 3A; HISTONE;

ACETYLATION; ANOXIA; ARTICLE; CELL LINE; DNA METHYLATION; ENZYMOLOGY; GENETIC EPIGENESIS; GENETICS; HUMAN; MALE; METABOLISM; PROSTATE TUMOR;

ACETYLATION; ANOXIA; CELL LINE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 70350771091     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp307     Document Type: Article

References (50)

1. Li, T., Vu, T.H., Ulaner, G.A., Littman, E., Ling, J.Q., Chen, H.L., Hu, J.F., Behr, B., Giudice, L. and Hoffman, A.R. (2005) IVF results in de novo DNA methylation and histone methylation at an IGF2-H19 imprinting epigenetic switch. Mol. Hum. Reprod., 9, 631-640.
2. Tanaka, T., Kato, H., Kojima, I., Onse, T., Son, D., Tawakami, T., Yatagawa, T., Inagi, R., Fujita, T. and Nangaku, M. (2006) Hypoxia and expression of Hypoxia-inducible factor in the aging kidney. J. Gerontol. A Biol. Sci. Med. Sci., 61, 795-805.
3. Aalami, O., Fang, T.D., Song, H.M. and Nacamuli, R.P. (2003) Physiological features of aging persons. Arch. Surg., 138, 1068-1076.
4. Sanchez-Chapado, M., Olmedilla, G., Cabeza, M., Donat, E. and Ruiz, A. (2003) Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Causcasion Mediterranean cales: an autopsy study. Prostate, 54, 238-247.
5. Ghafar, M.A., Anastasiadis, A.G., Chen, M.W., Burchardt, M., Olsson, L.E., Xie, H., Benson, M.C. and Buttyan, R. (2005) Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells.. Prostate, 54, 58-67.
6. Berger, A.P., Deibl, M., Leonhartsberger, N., Bektic, J., Horninger, W., Fritsche, G., Steiner, H., Pelzer, A., Bartsch, G. and Frauscher, F. (2005) Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia. Diabetologica, 48, 784-789.
7. Sampson, N., Untergasser, G., Plas, E. and Berger, P. (2007) The ageing male reproductive tract. J. Pathol., 211, 206-218.
8. Ord, J.J., Streeter, E.H., Roberts, I.S., Cranston, D. and Harris, A.L. (2005) Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer. Br. J. Cancer, 93, 346-354.
9. Calvisi, D.F., Ladu, S., Gorden, A., Farina, M., Lee, J.S., Conner, E.A., Schroeder, I., Factor, V.M. and Thorgeirsson, S.S. (2007) Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J. Clin. Invest., 117, 2713-2722.
10. Seligson, D.B., Horvath, S., Shi, T., Yu, H., Tze, S., Grunstein, M. and Kurdistani, S.K. (2005) Global histone modification patterns predict risk of prostate cancer recurrence. Nature, 435, 1262-1266.
11. Orr, J.A. and Hamilton, P.W. (2007) Histone acetylation and chromatin pattern in cancer. A Review. Anal. Quant. Cytol. Histol., 29, 17-31.
12. Kuendgen, A. and Gattermann, N. (2007) Valproic acid for the treatment of myeloid malignancies. Cancer, 110, 943-954.
13. Kihslinger, J.E. and Godley, L.A. (2007) The use of hypomethylating agents in the treatment of hematologic malignancies. Leuk. Lymphoma, 48, 1676-1695.
14. Santourlidis, S., Florl, A., Ackermann, R., Wirtz, H.C. and Schulz, W.A. (1999) High frequency of alterations in DNA methylation in adenocarcinoma of the prostate. Prostate, 39, 166-174.
15. Murrell, A., Ito, Y., Verde, G., Huddleston, J., Woodfine, K., Silengo, M.C., Spreafico, F., Perotto, D., De Crescenzo, A., Sparago, A. et al. (2008) Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer. PLoS ONE, 3, e1849.
16. Walsh, S., Gill, C., O'Neill, A., Fitzpatrick, J.M. and Watson, R.W.G. (2009) Hypoxia increases normal prostate epithelial cell resistance to receptor-mediated apoptosis via AKT activation. Int. J. Cancer, 124, 1871-1878.
17. Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A.H., Schlegelberger, B., Stein, H., Dorken, B., Jenuwein, T. and Schmitt, C.A. (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature, 436, 660-665.
18. Sun, P., Yoshizuka, N., New, L., Moser, B.A., Li, Y., Liao, R., Xie, C., Chen, J., Deng, O., Yamout, M. et al. (2007) PRAK is essential for ras-induced senescence and tumour suppression. Cell, 128, 295-308.
19. Courtois-Cox, S., Jones, S.L. and Cichowsky, K. (2008) Many roads lead to oncogene-induced senescence. Oncogene, 27, 2801-2809.
20. Cooper, C.S. and Foster, C.S. (2009) Concepts of epigenetics in prostate cancer development. Br. J. Cancer, 100, 240-245.
21. Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A.J., Barradas, M., Benguria, A., Zaballos, A., Flores, J.M., Barbacid, M. et al. (2005) Senescence in premalignant tumours. Nature, 436, 642.
22. Chang, B.D., Swift, M.E., Shen, M., Fang, J., Broude, E.V. and Roninson, I.B. (2002) Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc. Natl Acad. Sci. USA, 99, 389-394.
23. Zhang, Q., Wang, S.Y., Nottke, A.C., Rocheleau, J.V., Piston, D.W. and Goodman, R.H. (2006) Redox sensor CtBP mediates hypoxia-induced tumour cell migration. Proc. Natl Acad. Sci. USA, 103, 9029-9033.
24. Paliwal, S., Kovi, R.C., Nath, B., Chen, Y.W., Lewis, B.C. and Grossman, S.R. (2007) The alternative Reading Frame Tumor Suppressor Antagonizes Hypoxia-Induced Cancer Cell Migration via Interaction with the COOH-Terminal Binding Protein Corepressor. Cancer Res., 67, 9322-9329.
25. Zeelenberg, I.S., Ruuls-Van Stalle, L. and Roos, E. (2003) The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res., 63, 3833-3839.
26. Bernards, R. (2003) Cues for migration. Nature, 425, 247-248.
27. Araki, S., Omori, Y., Lyn, D., Singh, R.K., Meinbach, D.M., Sandman, Y., Lokeshwar, V.B. and Loekeshwar, B.L. (2007) Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer. Cancer Res., 67, 6854-6862.
28. Wegiel, B., Bjartell, A., Culig, Z. and Persson, J.L. (2008) Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival. Int. J. Cancer, 122, 1521-1529.
29. Tomita, K., Barnes, P.J. and Adcock, I.M. (2003) The effect of oxidative stress on histone acetylation and IL-8 release. Biochem. Biophys. Res. Comm., 301, 572-577.
30. Bartling, T.R. and Drumm, M.L. (2009) Oxidative stress causes IL8 promoter hyperacteylation in cystic fibrosis airway cell models. Am. J. Respir. Cell Mol. Biol., 40, 58-65.
31. Nile, C.J., Read, R.C., Akil, M., Duff, G.W. and Wilson, A.G. (2008) Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum., 58, 2686-2693.
32. Sullivan, K.E., Reddy, A.B., Dietzmann, K., Suriano, A.R., Kocieda, V.P., Stewart, M. and Bhatia, M. (2007) Epigenetic regulation of tumor necrosis factor alpha. Mol. Cell. Biol., 27, 5147-5160.
33. Hodge, D.R., Cho, E., Copeland, T.D., Guszczynski, T., Yang, E., Seth, A.K. and Farrar, W.L. (2007) IL-6 enhances the nuclear translocation of DNA cytosine-5-methyltransferase 1 (DNMT1) via phosphorylation of the nuclear localization sequence by the AKT kinase. Cancer Genomics Proteomics, 4, 387-398.
34. Meng, F., Wehbe-Janek, H., Henson, R., Smith, H. and Patel, T. (2008) Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene, 27, 378-386.
35. Wehbe, H., Henson, R., Meng, F., Mize-Berge, J. and Patel, T. (2006) Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression. Cancer Res., 66, 10517-10524.
36. Bartels, P.H., da Silva, V.D., Montironi, R., Hamilton, P.W., Thompson, D., Vaught, L. and Bartels, H.G. (1998) Chromatin texture signatures in nuclei from prostate lesions. Anal. Quant. Cytol. Histol., 20, 407-416.
37. Mohamed, M.A., Greif, P.A., Diamond, J., Sharaf, O., Maxwell, P., Montrioni, R., Young, R.A. and Hamilton, P.W. (2007) Epigenetic events, remodeling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. BJU Int., 99, 908-915.
38. Xia, X., Lemieux, M.E., Li, W., Carroll, J.S., Brown, M., Liu, X.S. and Kung, A.L. (2009) Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc. Natl Acad. Sci. USA, 106, 4260-4265.
39. Carrero, P., Okamoto, K., Coumailleau, P., O'Brien, S., Tanaka, H. and Poellinger, L. (2000) Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1 alpha. Mol. Cell. Biol., 20, 402-415.
40. Kallio, P.J., Okamoto, K., O'Brien, S., Carrero, P., Makino, Y., Tanaka, H. and Poellinger, L. (1998) Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. EMBO J., 17, 6573-6586.
41. Kato, H., Tamamizu-Kato, S. and Shibasaki, F. (2004) Histone deacetylase 7 associates with hypoxia-inducible factor 1a and increases transcriptional activity. J. Biol. Chem., 279, 41966-41974.
42. Kim, S.H., Jeong, J.W., Park, J.A., Lee, J.W., Seo, J.H., Jung, B.K., Bae, M.K. and Kim, K.W. (2007) Regulation of the HIF-1 alpha stability by histone deacetylases. Oncol. Rep., 17, 647-651.
43. Kenneth, N.S., Mudie, S., van Uden, P. and Rocha, S. (2008) SWI/SNF regulates the cellular response to hypoxia. J. Biol. Chem., 284, 4123-4131.
44. Chen, H., Yan, Y., Davidson, T.L., Shinkai, Y. and Costa, M. (2006) Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res., 66, 9009-9016.
45. Costa, M., Davidson, T.L., Chen, H., Ke, Q., Zhang, P., Yan, Y., Huang, C. and Kluz, T. (2005) Nickel carcinogenesis: epigenetics and hypoxia signalling. Mutat. Res., 592, 79-88.
46. Johnson, A.B., Denko, N. and Barton, M.C. (2008) Hypoxia induces a novel signature of chromatin modifications and global repression of transcription. Mutat. Res., 640, 174-179.
47. Shahrzad, S., Bertrand, K., Minhas, K. and Coomber, B.L. (2007) Induction of DNA hypomethylation by tumor hypoxia. Epigenetics, 2, 119-129.
48. Hermann, A., Gowher, H. and Jeltch, A. (2004) Biochemistry and biology of mammalian DNA methyltransferases. Cell. Mol. Life Sci., 61, 2571-2587.
49. Robertson, K.D., Uzvolgyi, E., Liang, G., Talmadge, C., Sumegi, J., Gonzales, F.A. and Jones, P.A. (1999) The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumours. Nucleic Acid Res., 27, 2291-2298.
50. Roll, J.D., Riverbark, A.G., Jones, W.D. and Coleman, W.B. (2008) DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines. Mol. Cancer, 7, 15-28.